LYMPHOMA, B-CELL MARGINAL ZONE

Clinical trials for LYMPHOMA, B-CELL MARGINAL ZONE explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, B-CELL MARGINAL ZONE trials appear

Sign up with your email to follow new studies for LYMPHOMA, B-CELL MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New pill shows promise for Tough-to-Treat blood cancers

Disease control Completed

This study tested an oral medication called LOXO-305 in Chinese adults with certain types of lymphoma or chronic leukemia that had returned or stopped responding to standard treatments. The main goal was to see how safe the drug was and how well it worked to control the cancer. R…

Matched conditions: LYMPHOMA, B-CELL MARGINAL ZONE

Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

LYMPHOMA, B-CELL MARGINAL ZONE

Get alerted when new LYMPHOMA, B-CELL MARGINAL ZONE trials appear

New pill shows promise for Tough-to-Treat blood cancers